StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.16+0.06 (+5.45%)

Close on Nov 19, 2026Market cap $60.88MP/E –Yield –

OKYO Pharma shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2022 it was 979M, up 45.5% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2022Mar 31, 2022979M+45.5%
FY2021Mar 31, 2021673M+13.0%
FY2020Mar 31, 2020595M–

More OKYO Pharma figures

See a number that looks wrong?